The Challenges of Polysubstance Use: Treatment and Management of Alcohol and Opioid Use Disorder Comorbidity

Presenter(s): Sarah Kawasaki, PhD, Director of Addictions Services, Pennsylvania Psychiatric Institute (PPI) Assistant Professor of Psychiatry and Internal Medicine at Penn State Hershey Medical Center

Note: Once the live event has passed, please allow two weeks for the recording and slide presentations to be posted.

Target Audience
This webinar is designed for:
Physicians, psychiatrists, psychologists, nurses, social workers, students and all interprofessional healthcare providers.

This webinar is accredited for:
The webinar provides a Certificate of Completion only. There is no CE credit designated for this learning activity.

Webinar Description: Alcohol is involved in over 20% of opioid-related overdose deaths, and co-occurring alcohol use disorder (AUD) significantly increases the risk of all-cause mortality among opioid use disorder (OUD) patients. Co-morbid opioid and alcohol use can be a potentially dangerous combination that can damage a person’s brain and body. Additionally, treating co-morbid opioid and alcohol use can lead to greater treatment complications compared to the treatment of either substance on its own. This webinar will discuss the use of medications and other integrated care strategies to improve treatment for co-morbid opioid and alcohol use disorders.

Educational Objectives:

• Understand the prevalence and health risks of co-morbid opioid and alcohol use
• Identify treatment implications related to co-morbid opioid and alcohol use
• Examine the benefits of integrated care to treat co-morbid opioid and alcohol use
• Discuss strategies to support long-term recovery from co-morbid opioid and alcohol use

Register Here